Tolerability of lorcaserin in obese and overweight patients.
Phase of Trial: Phase III
Latest Information Update: 20 Oct 2011
At a glance
- Drugs Lorcaserin (Primary)
- Indications Obesity
- Focus Adverse reactions
- 20 Oct 2011 New trial record
- 05 Oct 2011 Results presented at the 2011 Annual Meeting of the North American Association for the Study of Obesity.